4basebio shares jump on new marketing tie-up with US-based Genezen
26th Aug 2026 13:24
(Alliance News) - 4basebio PLC on Wednesday saw its shares jump after disclosing a new strategic collaboration and marketing agreement. Read More
| Price | 475.00p on 27-08-2026 at 18:35:06 |
|---|---|
| Change | 0.00p 0% |
| Buy | 500.00p |
| Sell | 450.00p |
| Last Trade: | Buy 18.00 at 492.50p |
| Day's Volume: | 52 |
| Last Close: | 475.00p |
| Open: | 475.00p |
| ISIN: | GB00BMCLYF79 |
| Day's Range | 475.00p - 475.00p |
| 52wk Range: | 425.00p - 885.00p |
| Market Capitalisation: | £73.55m |
| VWAP: | 476.18654p |
| Shares in Issue: | 15.48m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
4basebio Plc (4BB) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 18 | 492.50p | Ordinary |
10:52:26 - 27-Aug-26 |
| Sell* | 16 | 467.55p | Ordinary |
10:26:21 - 27-Aug-26 |
| Sell* | 18 | 467.55p | Ordinary |
09:32:24 - 27-Aug-26 |
| Buy* | 1,000 | 490.00p | Suspected BUY Trade |
11:00:20 - 26-Aug-26 |
| Buy* | 4 | 500.00p | SI Trade |
08:00:22 - 26-Aug-26 |
| Buy* | 4 | 500.00p | Ordinary |
08:00:22 - 26-Aug-26 |
| Sell* | 2 | 467.55p | Ordinary |
08:00:20 - 26-Aug-26 |
| Buy* | 407 | 490.00p | Ordinary |
15:22:29 - 25-Aug-26 |
| Buy* | 9 | 490.00p | Ordinary |
12:28:19 - 25-Aug-26 |
| Buy* | 9 | 490.00p | Ordinary |
10:30:18 - 25-Aug-26 |
4basebio Plc (4BB) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 26th Aug 2026 7:00 am | PRN | 4basebio Enters into Strategic Collaboration and Marketing Agreement with Genezen to Advance Synthetic, Cell-Free DNA Platforms for Next-Generation Viral Vector Manufacturing |
| 22nd Jul 2026 7:00 am | PRN | Grant of Options & Director/PDMR Dealing |
| 8th Jul 2026 7:00 am | PRN | Director Appointment |
| 30th Jun 2026 5:37 pm | PRN | Result of AGM & Issue of Options |
| 16th Jun 2026 7:00 am | PRN | Notice of Investor Presentation |
| 15th Jun 2026 7:00 am | PRN | 4basebio Appoints Dr. Jeff Coller to Strategic Advisory Board |
| 5th Jun 2026 7:00 am | PRN | Notice of Annual General Meeting |
| 22nd May 2026 9:10 am | PRN | Director Dealing |
| 20th May 2026 7:02 am | PRN | Final Results and Notice of AGM |
| 20th May 2026 7:00 am | PRN | 4basebio Signs Clinical Supply Agreement to Support Phase II Clinical Trial |